Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion
Today Eli Lilly and Company announced its four-year grant of $4,384,000 to the World Health Organization (WHO) for scaling up its global capacity to manage multi- drug resistant tuberculosis (MDR-TB) programs.
The grant covers four activities, starting with the technical assistance the WHO will provide to developing countries that the Global Fund to Fight AIDS, Tuberculosis […]
